Cefepime versus ceftazidime as empiric monotherapy for fever and neutropenia in children with cancer

Pediatric Infectious Disease Journal

Volumn 21, Issue 3, 2002, Pages 203-209

  Chuang, Yu Yu ^a,b   Hung, Iou Jih ^b   Yang, Chao Ping ^b   Jaing, Tang Her ^b   Lin, Tzou Yien ^b   Huang, Yhu Chering ^b  

^a St Mary's Hospital   (Taiwan)

^b CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

Author keywords

Cefepime; Ceftazidime; Childhood cancer; Febrile neutropenia

Indexed keywords

CEFEPIME; CEFTAZIDIME;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISEASE COURSE; DISEASE DURATION; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; ERADICATION THERAPY; FEBRILE NEUTROPENIA; FEMALE; FEVER; HUMAN; INFANT; INFECTION RATE; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUTROPHIL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; TREATMENT OUTCOME; VOMITING;

ADOLESCENT; BACTERIAL INFECTIONS; CEFTAZIDIME; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; FEMALE; FEVER; HUMANS; INFANT; MALE; NEOPLASMS; NEUTROPENIA; TREATMENT OUTCOME;

EID: 0036184983     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200203000-00009     Document Type: Article

References (22)

1. Management of fever in patients with cancer and treatment-induced neutropenia
2. 1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever
3. Cefepime monotherapy for the empiric treatment of fever in granulocytopenic cancer patients
4. Is monoherapy for febrile neutropenia still a viable alternative?
5. Cefepime the next generation?
6. Bacteriologic and clinical applications of a new extended-spectrum parenteral cephalosporin
7. Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: A 1997 surveillance trial in 102 medical centers in the United States
8. Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient
9. Cefepime vs. ceftazidime as empiric therapy of febrile neutropenic patients
10. Open randomized study of cefepime vs. piperacillin-gentamicin for treatment of febrile neutropenic cancer patients
11. Cefepime vs. imipenemcilastatin as empiric monotherapy in 400 febrile patients with short duration neutropenia
12. A comparative study of cefepime vs. ceftazidime as empiric therapy of febrile episodes in neutropenic patients
13. Cefepime vs. ceftazidime as empiric therapy for fever in neutropenic patients with cancer
14. Cefepime/amikacin vs. ceftazidime/amikacin as empiric therapy for febrile episodes in neutropenic patients: A comparative study
15. Comparative study of cefepime vs. ceftazidime in the empiric treatment of pediatric cancer patients with fever and neutropenia
16. Randomized comparison of cefepime vs. ceftazidime monotherapy for fever and neutropenia in children with solid tumors
17. Evaluation of new anti-infective drugs for the treatment of febrile episodes in neutropenic patients
18. The design, analysis, and reporting of clinical trials on empiric antibiotic management of neutropenic patient: Report of consensus panel from the Immunocompromised Host Society
19. A comparison of outcome from febrile neutropenic episodes in children compared with adults: Results from four EORTC studies
20. Changing epidemiology of infections in patients with neutropenia and cancer: Emphasis on gram-positive and resistant bacteria
21. Contemporary antimicrobial susceptibility patterns of bacterial pathogens commonly associated with febrile patients with neutropenia